Año: 2005
Journal Impact Factor (JIF): 1.7850
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 102/193 | Q3 | T2 | D6 |
| INFECTIOUS DISEASES | SCIE | 33/43 | Q4 | T3 | D8 |
Año:
2011
CiteScore:
3,600
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| General Medicine | 1101/3161 | Q2 | T2 | D4 |
| Infectious Diseases | 79/220 | Q2 | T2 | D4 |
| Pharmacology (medical) | 78/214 | Q2 | T2 | D4 |
SJR año:
2002
Factor de Impacto:
0,620
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology (medical) | 48/178 | Q2 | T1 | D3 |
| Infectious Diseases | 56/148 | Q2 | T2 | D4 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Toro, Carlos | Hospital Carlos Iii (Spain) |
| 2 | Soriano, Vincent | Hospital Carlos Iii (Spain) |
| 3 | Tuset, Concepción | Hospital Carlos Iii (Spain) |
| 4 | Aguilera, Antonio | Hospital Carlos Iii (Spain) |
| 5 | Caballero, Estrella | Hospital Carlos Iii (Spain) |
| 6 | de Lejarazu, Raul Ortiz | Hospital Carlos Iii (Spain) |
| 7 | Rodés, Berta | Hospital Carlos Iii (Spain) |
| # | Autoría grupal | Afiliación |
| 1 | HIV-2/HTLC Spanish Study Group | Sin datos () |
| 2 | Calderón, E. (HIV-2/HTLC Spanish Study Group) | Hospital Carlos Iii (Spain) |
| 3 | Medrano, F. J. (HIV-2/HTLC Spanish Study Group) | Hospital Carlos Iii (Spain) |